drugset / Trial / NCT00266565
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
NaSingle-groupOpen-labelTreatment
Summary
Toxicity of anti-IL-5
Timeline
- Start
- 2001-12
- Primary completion
- 2005-04
- Completion
- 2005-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mepolizumab | Monoclonal antibody | 10 mg/kg | Intravenous |